Dr. Philip A. Starr, MD

Dr. Starr practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Starr's NPI, 1669439246, was assigned on April 27, 2006. Dr. Starr graduated from Harvard Medical School in 1989. Dr. Starr holds California license G84550.

Dr. Starr's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Starr's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Starr to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Starr practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Starr's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Starr is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Starr's licenses on file in 2 states: California and Georgia.

Dmand AI lists craniotomy among the conditions Dr. Starr treats.

CMS data shows 124 Medicare services from Dr. Starr across 7 procedure codes in 2024, for 84 Medicare patients. Medicare paid $56,748 for them.

CMS counts 84 Medicare patients who saw Dr. Starr in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have parkinson's disease, and 61% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Starr's median patient age at 69, with 29% women.

In 2019, Dr. Starr wrote 14 Medicare Part D claims. They cover 1 drug, with $57 in total drug cost. In 2018, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Starr for performance year 2024, reported as part of a group. Dr. Starr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Starr as offering telehealth.

Dmand AI links 233 papers to Dr. Starr, published from 2004 to 2025. 2021 was the busiest year, with 24. The most frequent topics are Deep Brain Stimulation, Parkinson Disease and Subthalamic Nucleus. Dr. Starr has published most often in Stereotact Funct Neurosurg. Dr. Starr's most frequent co-authors are Jill Louise Ostrem, MD, Simon James Little, MBBS, PhD and Paul S. Larson, MD.

Dmand AI links Dr. Starr to 3 clinical trials. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Dystonia. University of California, San Francisco sponsors the most, 2.

CMS Open Payments shows 170 general payments to Dr. Starr from 9 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 45% of the total. Medtronic USA, Inc. paid the most, $13,041. It also lists 3 research payments totaling $17,786 from 2016 to 2018.

Dmand AI lists 2 awards for Dr. Starr, most recently CMS Stage 1 EHR in 2013.

Dr. Starr graduated from Harvard Medical School in 1989. Dr. Starr is a member of AANS, CNS and MDS.

Dr. Starr is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.